BackView on Congress.gov
119th Congress•House

HR. 7953

Committee

To accelerate patient access to innovative medicines and clinical trials for life-threatening diseases by establishing a reciprocal approval mechanism with trusted international regulatory authorities.

Latest action
2026-03-17
Referred to the House Committee on Energy and Commerce.
Introduced
2026-03-17
Cosponsors
1
Origin
House
Subjects
—

Key actions

  1. 2026-03-17IntroReferral
    Introduced in House
  2. 2026-03-17IntroReferral
    Referred to the House Committee on Energy and Commerce.
  3. 2026-03-17IntroReferral
    Introduced in House

Bill text versions

    No text versions found.

Related bills

No related bills listed.